Nanoscaled biosensors: reading epigenetic signatures to improve breast cancer detection and treatment (2008–2011)

Due to limitations with current diagnostic and prognostic tools, many breast cancer patients are subjected to unnecessary adjuvant therapies, while others relapse and die despite having been treated according to state-of-the-art clinical guidelines. This situation indicates a need for a novel and innovative technology to develop clinically useful prognostic tools. This project seeks to address this by developing nanoscaled biosensors for breast cancer.
Grant type:
Cancer Australia
  • UQ-CSIRO Chair in Personalised Nano
    Australian Institute for Bioengineering and Nanotechnology
    Professorial Research Fellow
    School of Chemistry and Molecular Biosciences
    Faculty of Science
Funded by:
Cancer Australia